Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Midterm blue wave brings pharma and MFN under new scrutiny
Pharma leaders should prepare for scrutiny as a blue wave of federal legislators attempt to pry open Trump's MFN deals.
Donavyn Coffey
Nov 12, 2026 2:22pm
FDA's CNPV speedy review program, CRL disclosures go quiet
Nov 12, 2026 11:26am
Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care
Brought to you by
Daiichi Sankyo, Inc.
Orzeyful gets off to races in US with 'lighter' DEA schedule
Nov 12, 2026 11:16am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Regulatory tracker: Lilly nabs 1st China oral obesity drug nod
Nov 12, 2026 9:40am
